Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | PI4KA | P42356 | 1/20 | 0.40 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.40 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.40 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | GMPS | P49915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL439243 | 0.87 | SLC28A1 (0.56) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL29799646 | 0.87 | SLC28A1 (0.56) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL28092439 | 0.84 | SLC28A1 (0.42) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL29406372 | 0.84 | SLC28A1 (0.42) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL27220667 | 0.84 | SLC28A1 (0.42) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL4783231 | 0.81 | SLC28A1 (0.39) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL28042204 | 0.80 | SLC28A1 (0.39) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL7220604 | 0.80 | SLC28A1 (0.39) | SLC28A1ADORA3ADORA2A | |
| SCHEMBL17460353 | 0.80 | ADORA2A (0.42) | SLC28A1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL41364 | 0.79 | PI4KA (0.43) | SLC28A1PI4KAPI4K2BPI4K2API4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3044228-B1 | HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH | CHEMGENES CORP (US) | 2021-04-07 | — | — | EP | disclosed |
| CN-105916873-B | Efficient synthesis of long RNAs using the reverse method | 坎姆根公司 | 2020-06-19 | — | — | CN | disclosed |
| US-10167308-B2 | Highly efficient synthesis of long RNA using reverse direction approach | CHEMGENES CORPORATION (US) | 2019-01-01 | — | — | US | disclosed |
| US-9969764-B2 | Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces | CHEMGENES CORPORATION | 2018-05-15 | — | — | US | disclosed |
| US-9884885-B2 | Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis | CHEMGENES CORPORATION (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170037076-A1 | DITHIOLANE FUNCTIONALIZED NUCLEOSIDE AMIDITES AND SUPPORTS FOR STRONGER IMMOBILIZATION OF BIO-MOLECULES ON SOLID SURFACES | CHEMGENES CORPORATION | 2017-02-09 | — | — | US | disclosed |
| EP-2326656-B1 | RNA SYNTHESIS - PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3' - END | CHEMGENES CORP (US) | 2017-01-25 | — | — | EP | disclosed |
| EP-3060572-A1 | DITHIOLANE FUNCTIONALIZED NUCLEOSIDE AMIDITES AND SUPPORTS FOR STRONGER IMMOBILIZATION OF BIO-MOLECULES ON SOLID SURFACES | Chemgenes Corporation (US) | 2016-08-31 | — | — | EP | disclosed |
| US-20160200759-A1 | HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH | CHEMGENES CORPORATION | 2016-07-14 | — | — | US | disclosed |
| WO-2015061507-A1 | DITHIOLANE FUNCTIONALIZED NUCLEOSIDE AMIDITES AND SUPPORTS FOR STRONGER IMMOBILIZATION OF BIO-MOLECULES ON SOLID SURFACES | CHEMGENES CORPORATION (US) | 2015-04-30 | — | — | WO | disclosed |
| US-8981076-B2 | Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis | CHEMGENES CORPORATION (US) | 2015-03-17 | — | — | US | disclosed |
| US-20130072670-A1 | RNA SYNTHESIS-PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3'-END | CHEMGENES CORPORATION (US) | 2013-03-21 | — | — | US | disclosed |
| US-8309707-B2 | RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end | CHEMGENES CORPORATION (US) | 2012-11-13 | — | — | US | disclosed |
| US-20120065386-A1 | SYNTHESIS OF LABILE BASE PROTECTED - MODIFIED DEOXY & MODIFIED RIBO NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND SUPPORTS AND THEIR USE IN HIGH PURITY OLIGONUCLEOTIDE SYNTHESIS | CHEMGENES CORPORATION | 2012-03-15 | — | — | US | disclosed |
| EP-2326656-A2 | RNA SYNTHESIS - PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3' - END | Chemgenes Corporation (US) | 2011-06-01 | — | — | EP | disclosed |
| US-20110015382-A1 | Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis | CHEMGENES CORPORATION (US) | 2011-01-20 | — | — | US | disclosed |
| US-20100324278-A1 | RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end | CHEMGENES CORPORATION | 2010-12-23 | — | — | US | disclosed |
| WO-2010027512-A9 | RNA SYNTHESIS - PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3' - END | CHEMGENES CORPORATION (US) | 2010-04-22 | — | — | WO | disclosed |
| WO-2010027512-A2 | RNA SYNTHESIS - PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3' - END | CHEMGENES CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015382-A1 | Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis | RNGTT, RNMT, NSUN2 | SLC28A1 422/4885PI4KA 4766/4885PI4K2B 4603/4885 |
| US-20120065386-A1 | SYNTHESIS OF LABILE BASE PROTECTED - MODIFIED DEOXY & MODIFIED RIBO NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND SUPPORTS AND THEIR USE IN HIGH PURITY OLIGONUCLEOTIDE SYNTHESIS | RNMT, POLRMT, RNGTT | SLC28A1 709/4885PI4KA 4421/4885PI4K2B 2780/4885 |
| US-20100324278-A1 | RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end | NSUN3, RNMT, NSUN2 | SLC28A1 469/4885PI4KA 2084/4885PI4K2B 1911/4885 |
| US-20130072670-A1 | RNA SYNTHESIS-PHOSPHORAMIDITES FOR SYNTHETIC RNA IN THE REVERSE DIRECTION, AND APPLICATION IN CONVENIENT INTRODUCTION OF LIGANDS, CHROMOPHORES AND MODIFICATIONS OF SYNTHETIC RNA AT THE 3'-END | NSUN3, RNMT, NSUN2 | SLC28A1 469/4885PI4KA 2084/4885PI4K2B 1911/4885 |
| US-10167308-B2 | Highly efficient synthesis of long RNA using reverse direction approach | NSUN3, POLRMT, METTL16 | SLC28A1 3085/4885PI4KA 2438/4885PI4K2B 2706/4885 |
| US-20160200759-A1 | HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH | NSUN3, POLRMT, METTL16 | SLC28A1 3085/4885PI4KA 2438/4885PI4K2B 2706/4885 |
| US-20170037076-A1 | DITHIOLANE FUNCTIONALIZED NUCLEOSIDE AMIDITES AND SUPPORTS FOR STRONGER IMMOBILIZATION OF BIO-MOLECULES ON SOLID SURFACES | RNGTT, DIMT1, ADAR | SLC28A1 277/4885PI4KA 3620/4885PI4K2B 3774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.